Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroshi Kanetake is active.

Publication


Featured researches published by Hiroshi Kanetake.


Journal of Japanese Society for Dialysis Therapy | 1983

Successful pregnancy and delivery in a patient on chronic hemodialysis

Akihito Jodai; Atushi Imamura; Toshio Kitayama; Hideshi Shimomae; Jun Yamada; Yasuyuki Kusaba; Hiroshi Kanetake; Kazuhiko Shindo; Yutaka Saito; Takashi Harada; Yoshinobu Hirai; Yoshiyuki Ozono; Masahiro Kawatomi; Shigeo Ura; Kohei Hara; Masako Yasunaga; Makoto Yoshida; Masayuki Inoue

血液透析患者の妊娠を継続させ, 正常な分娩を行わせることは困難であるが, 今回我々は血液透析歴4年になる32歳女性の妊娠, 分娩で母児ともに順調な経過をとった症例を経験したので報告する.症例は32歳の1回経妊0回経産の婦人. 昭和50年4月, 糸球体腎炎と診断され, 昭和52年12月より慢性腎不全のもとに血液透析を開始した. 月経歴は血液透析開始後も変化はみられなかった. 昭和55年7月に結婚, 昭和56年9月初旬に腹部膨隆に気づき産婦人科を受診し, 妊娠24週と診断された. 妊娠31週で切迫早産と診断され, 妊娠および胎児管理のため当科に緊急入院した. ただちに産科で妊娠, 胎児の管理を行う一方, 妊娠38週まで妊娠の継続を目標に, 1) 貧血の改善, 2) 頻回透析により血清BUN, Crを低値におさえる, 3) 食事は普通食, の如く決定した. 切迫早産の徴候が再度みられた妊娠33-34週はFOY透析, 以後は通常の半量のヘパリン化透析, 同時に凝固系のチェックを週3回の割に行った. 昭和56年11月14日, 妊娠38週6日に経膣分娩にて男児を出産, 出血量1,036g, 児の体重2,070g, apgar指数10点, 外表奇形なく低血糖症状がみられたものの良好な経過をとった. 母親は出産後1度中等量の出血をみたものの透析による出血への影響もほとんどみられず, また透析時の困難もなく良好な経過であった.


Kidney International | 1983

In vitro evidence from tissue cultures to prove existence of rabbit and human renotropic growth factor

Nobuto Yamamoto; Hiroshi Kanetake; Jun Yamada


Kidney International | 1983

Renotropic growth factor found in cancer patient sera after removal of cancer-bearing kidney

Jun Yamada; Hiroshi Kanetake; Yutaka Saito; Atsushi Kondo; Nobuto Yamamoto


/data/revues/00904295/v65i6/S0090429505001160/ | 2011

Decreased cellular membrane expression of gap junctional protein, connexin 43, in rat detrusor muscle with chronic partial bladder outlet obstruction

Kenichi Mori; Mitsuru Noguchi; Manabu Matsuo; Koichiro Nomata; Takashi Suematsu; Hiroshi Kanetake


Oncogene Proteins: Structure, Functions and Analyses | 2008

Non-receptor Protein Tyrosine Kinase Fes as a Candidate for Anticancer Molecular Targeting Therapy

Shigeru Kanda; Yasuyoshi Miyata; Hiroshi Kanetake


ics.org | 2007

Expression of AT1 on the interstitial cells in suburothelial layer

Shohei Tobu; Mitsuru Noguchi; Teppei Hatada; Tomohiro Matsuo; Kenichi Mori; Manabu Matsuo; Hiroshi Kanetake


The Nishinihon journal of urology | 2007

CLINICAL STUDY OF RENAL ANGIOMYOLIPOMA IN KYUSHU DISTRICT : 14th KYUSHU COOPERATIVE UROLOGICAL RESEARCH

Shigehiko Koga; Hiroshi Kanetake; Seiji Naito; Hirofumi Koga; Masayuki Nakagawa; Motoshi Kawahara; Yoshihide Ogawa; Kimio Sugaya; Zenjiro Masaki; Jiro Uozumi; Shoichi Ueda; Masaki Yoshida; Yukio Osada; Yoshihiro Hasui; Masatoshi Tanaka; Kazuhiro Oshima; Yoshiharu Hiratsuka; Kei Matsuoka; Shigeru Miyahara; Masanori Noguchi; Yoshio Nomura; Hiromitsu Mimata; Tetsuro Matsumoto; Naohiro Fujimoto


Acta medica Nagasakiensia | 2001

Upregulation of CA 19-9 in the Mouse Kidney Following Unilateral Ureteral Obstruction

Li Shengwen; Kouichiro Nomata; Tomayoshi Hayashi; Daiyu Aoki; Shigeru Kanda; Hiroshi Kanetake


Acta medica Nagasakiensia | 2001

Elevated Expression of Pyrimidine Nucleoside Phosphorylase (PyNPase) in Renal Cell Carcinoma Tissue

Kanenori Maeda; Mitsuru Noguchi; Koichiro Nomata; Shigehiko Koga; Hiroshi Kanetake


西日本泌尿器科 | 1999

A RANDOMIZED TRIAL OF CHEMO-ENDOCRINE THERAPY VERSUS ENDOCRINE THERAPY ALONE IN NEWLY DIAGNOSED PATIENTS WITH ADVANCED PROSTATE CANCER

Hideki Sakai; Takefumi Shono; Yuzo Minami; Hiroshi Kanetake; Yutaka Saito; Yasuyuki Kusaba; Tanetoshi Hara; Kazuhiko Shindo; Yoko Kubota; Teruhiro Nakada

Collaboration


Dive into the Hiroshi Kanetake's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shigeru Kanda

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge